288 related articles for article (PubMed ID: 19754465)
41. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid.
Arslan M; Vurucu S; Balamtekin N; Unay B; Akin R; Kurt I; Ozcan O
Brain Dev; 2009 Jun; 31(6):405-10. PubMed ID: 18814980
[TBL] [Abstract][Full Text] [Related]
42. [Anticonvulsants treatment of psychiatric disorder in elderly patients].
Bidzan L
Przegl Lek; 2006; 63(7):583-7. PubMed ID: 17203814
[TBL] [Abstract][Full Text] [Related]
43. Valproate: past, present, and future.
Johannessen CU; Johannessen SI
CNS Drug Rev; 2003; 9(2):199-216. PubMed ID: 12847559
[TBL] [Abstract][Full Text] [Related]
44. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
45. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
Ugras M; Yakinci C
Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
[TBL] [Abstract][Full Text] [Related]
46. Valproic acid as anti-cancer drug.
Michaelis M; Doerr HW; Cinatl J
Curr Pharm Des; 2007; 13(33):3378-93. PubMed ID: 18045192
[TBL] [Abstract][Full Text] [Related]
47. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
48. [Dementia and extrapyramidal problems caused by long-term valproic acid].
Masmoudi K; Gras-Champel V; Bonnet I; Pannier M; Masson H; Rosa A; Andréjak M
Therapie; 2000; 55(5):629-34. PubMed ID: 11201978
[TBL] [Abstract][Full Text] [Related]
49. Study of the structural and electronic properties of valproic acid and new derivatives used as anticonvulsant agents.
Comelli NC; Lobayan RM; Castro EA; Jubert AH
J Phys Chem A; 2011 Mar; 115(9):1686-700. PubMed ID: 21309610
[TBL] [Abstract][Full Text] [Related]
50. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
[TBL] [Abstract][Full Text] [Related]
51. Anticonvulsant efficacy of valproate-like carboxylic acids: a potential target for anti-bipolar therapy.
Azab AN; Greenberg ML
Bipolar Disord; 2007 May; 9(3):197-205. PubMed ID: 17430293
[TBL] [Abstract][Full Text] [Related]
52. Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures.
Gibbons HM; Smith AM; Teoh HH; Bergin PM; Mee EW; Faull RL; Dragunow M
Neurobiol Dis; 2011 Jan; 41(1):96-103. PubMed ID: 20816784
[TBL] [Abstract][Full Text] [Related]
53. Valproate-induced insulin resistance and obesity in children.
Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
[TBL] [Abstract][Full Text] [Related]
54. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
Shimshoni JA; Yagen B; Pessah N; Wlodarczyk B; Finnell RH; Bialer M
Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754
[TBL] [Abstract][Full Text] [Related]
55. Neurochemical underpinnings in bipolar disorder and epilepsy.
Amann B; Grunze H
Epilepsia; 2005; 46 Suppl 4():26-30. PubMed ID: 15938708
[TBL] [Abstract][Full Text] [Related]
56. Molecular and therapeutic potential and toxicity of valproic acid.
Chateauvieux S; Morceau F; Dicato M; Diederich M
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798865
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic monitoring of valproate in psychiatry: how far have we progressed?
Fleming J; Chetty M
Clin Neuropharmacol; 2006; 29(6):350-60. PubMed ID: 17095899
[TBL] [Abstract][Full Text] [Related]
58. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y
J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614
[TBL] [Abstract][Full Text] [Related]
59. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
[TBL] [Abstract][Full Text] [Related]
60. Crystal structure and anticonvulsant activity of (+/-)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol.
Moon SC; Echeverría GA; Punte G; Ellena J; Bruno-Blanch LE
Carbohydr Res; 2007 Aug; 342(11):1456-61. PubMed ID: 17548067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
